Quinn, K. A. Et Al. 2022. Use of F-18-fluorodeoxyglucose positron emission tomography to standardize clinical trial recruitment in Takayasu's arteritis. RHEUMATOLOGY , vol.61, no.10 , 4047-4055.

Quinn, K. A., Alessi, H., Ponte, C., Rose, E., Ahlman, M. A., Redmond, C., ... Luo, Y.(2022). Use of F-18-fluorodeoxyglucose positron emission tomography to standardize clinical trial recruitment in Takayasu's arteritis. RHEUMATOLOGY , vol.61, no.10, 4047-4055.

Quinn, Kaitlin Et Al. "Use of F-18-fluorodeoxyglucose positron emission tomography to standardize clinical trial recruitment in Takayasu's arteritis," RHEUMATOLOGY , vol.61, no.10, 4047-4055, 2022

Quinn, Kaitlin A. Et Al. "Use of F-18-fluorodeoxyglucose positron emission tomography to standardize clinical trial recruitment in Takayasu's arteritis." RHEUMATOLOGY , vol.61, no.10, pp.4047-4055, 2022

Quinn, K. A. Et Al. (2022) . "Use of F-18-fluorodeoxyglucose positron emission tomography to standardize clinical trial recruitment in Takayasu's arteritis." RHEUMATOLOGY , vol.61, no.10, pp.4047-4055.

@article{article, author={Kaitlin A. Quinn Et Al. }, title={Use of F-18-fluorodeoxyglucose positron emission tomography to standardize clinical trial recruitment in Takayasu's arteritis}, journal={RHEUMATOLOGY}, year=2022, pages={4047-4055} }